Isofol Medical AB Achieves FDA Milestone for Arfolitixorin, Advancing Cancer Treatment
Isofol Medical AB has successfully completed a pre-IND meeting with the FDA for its cancer treatment candidate arfolitixorin, a significant step forward in bringing a novel folate-based therapy to market.
2 minutes to read